Sionna Therapeutics (SION) Common Equity (2024 - 2026)
Quarterly results put Common Equity at $288.2 million for Q1 2026, down 18.07% from a year ago — trailing twelve months through Mar 2026 was $288.2 million (down 18.07% YoY), and the annual figure for FY2025 was $306.8 million, up 287.42%.
Sionna Therapeutics has reported Common Equity over the past 3 years, most recently at $288.2 million for Q1 2026.
- Common Equity reached $288.2 million in Q1 2026 per SION's latest filing, down from $306.8 million in the prior quarter.
- Across five years, Common Equity topped out at $351.8 million in Q1 2025 and bottomed at -$163.7 million in Q4 2024.
- Median Common Equity over the past 3 years was $288.2 million (2026), compared with a mean of $114.8 million.
- The largest annual shift saw Common Equity surged 379.0% in 2025 before it decreased 18.07% in 2026.
- Over 3 years, Common Equity stood at -$163.7 million in 2024, then soared by 287.42% to $306.8 million in 2025, then dropped by 6.07% to $288.2 million in 2026.
- Business Quant data shows Common Equity for SION at $288.2 million in Q1 2026, $306.8 million in Q4 2025, and $321.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -1.42 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 35.63 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 31.42 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 13.21 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Sionna Therapeutics | 1.87 Bn | 1.87 Bn | - | 288.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 288.21 Mn |
| Dec 31, 2025 | 306.83 Mn |
| Sep 30, 2025 | 321.67 Mn |
| Jun 30, 2025 | 336.43 Mn |
| Mar 31, 2025 | 351.77 Mn |
| Dec 31, 2024 | -163.71 Mn |
| Sep 30, 2024 | -148.55 Mn |
| Jun 30, 2024 | -133.77 Mn |
| Mar 31, 2024 | -126.08 Mn |